Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15742344rdf:typepubmed:Citationlld:pubmed
pubmed-article:15742344lifeskim:mentionsumls-concept:C0021390lld:lifeskim
pubmed-article:15742344lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:15742344lifeskim:mentionsumls-concept:C2348767lld:lifeskim
pubmed-article:15742344lifeskim:mentionsumls-concept:C0072642lld:lifeskim
pubmed-article:15742344pubmed:issue12lld:pubmed
pubmed-article:15742344pubmed:dateCreated2005-3-8lld:pubmed
pubmed-article:15742344pubmed:abstractTextPycnogenol was administered for 10 days by gavage to Sprague-Dawley rats fed an elemental diet, then inflammatory bowel disease (IBD) was induced by intrarectal administration of ethanol 2,4,6-trinitrobenzene sulfonic acid (TNBS). Twelve hours after TNBS treatment, the rats were killed, the colon was assessed by a macroscopic damage score and mucosa homogenate was assayed for myeloperoxidase (MPO) activity. The supplementation of pycnogenol significantly inhibited the macroscopic damage score and MPO activity in a dose-dependent manner. These results suggested that pycnogenol ameliorates TNBS-induced inflammation by radical scavenging activity, and may have beneficial effects as a supplement in enteral nutrition for IBD.lld:pubmed
pubmed-article:15742344pubmed:languageenglld:pubmed
pubmed-article:15742344pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15742344pubmed:citationSubsetIMlld:pubmed
pubmed-article:15742344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15742344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15742344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15742344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15742344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15742344pubmed:statusMEDLINElld:pubmed
pubmed-article:15742344pubmed:monthDeclld:pubmed
pubmed-article:15742344pubmed:issn0951-418Xlld:pubmed
pubmed-article:15742344pubmed:authorpubmed-author:HasegawaNobor...lld:pubmed
pubmed-article:15742344pubmed:authorpubmed-author:MochizukiMiya...lld:pubmed
pubmed-article:15742344pubmed:copyrightInfo2004 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:15742344pubmed:issnTypePrintlld:pubmed
pubmed-article:15742344pubmed:volume18lld:pubmed
pubmed-article:15742344pubmed:ownerNLMlld:pubmed
pubmed-article:15742344pubmed:authorsCompleteYlld:pubmed
pubmed-article:15742344pubmed:pagination1027-8lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:meshHeadingpubmed-meshheading:15742344...lld:pubmed
pubmed-article:15742344pubmed:year2004lld:pubmed
pubmed-article:15742344pubmed:articleTitleTherapeutic efficacy of pycnogenol in experimental inflammatory bowel diseases.lld:pubmed
pubmed-article:15742344pubmed:affiliationDepartment of Health and Nutrition, School of Health and Human Life, Nagoya Bunri University, Inazawa, Japan.lld:pubmed
pubmed-article:15742344pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15742344lld:pubmed